-+ 0.00%
-+ 0.00%
-+ 0.00%

LEADS BIOLABS’ OPAMTISTOMIG (PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED FDA FAST TRACK DESIGNATION FOR FIRST-LINE ADVANCED OR METASTATIC BILIARY TRACT CANCER

Reuters·10/12/2026 01:49:01